Table 4.
Cardiovascular Events and Mortality Rates With SGLT-2 Inhibitors in Meta-Analyses of Phase 2 to 3 Randomized Controlled Trials (Excluding Final Results of CANVAS Program and Results of EMPA-REG OUTCOME)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.